sever
acut
respiratori
syndrom
coronaviru
sarscov
first
emerg
caus
sar
epidem
result
fatal
rate
advanc
metagenom
techniqu
allow
identif
sarslik
coronavirus
slcov
sequenc
share
high
homolog
human
sarscov
epidem
strain
wildlif
bat
present
concret
evid
bat
origin
natur
reservoir
sarscov
applic
revers
genet
enabl
character
bat
cov
predict
potenti
caus
diseas
human
knowledg
gain
studi
valuabl
surveil
prepar
possibl
futur
outbreak
caus
spillov
bat
slcov
sever
acut
respiratori
syndrom
coronaviru
sarscov
first
emerg
infecti
agent
caus
sever
sometim
fatal
respiratori
diseas
human
viru
spread
rapidli
southern
china
hong
kong
rest
world
result
sar
epidem
last
month
eventu
put
end
implement
intens
public
health
measur
epidem
caus
total
infect
fatal
rate
consider
amount
social
hardship
econom
loss
ever
sinc
emerg
sar
much
effort
made
understand
origin
emerg
sarscov
crossspeci
jump
event
led
emerg
sarscov
human
small
anim
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procynonoid
sold
liveanim
wet
market
guangdong
provinc
southern
china
immedi
sourc
viru
transmit
human
sar
outbreak
nonetheless
numer
observ
suggest
palm
civet
small
anim
mere
conduit
sarscov
transmiss
human
rather
natur
wildlif
reservoir
harbor
viru
firstli
viral
rna
detect
antisar
sera
detect
civet
marketplac
farm
wildlif
civet
indic
palm
civet
wide
infect
sarscov
addit
sequenc
comparison
variou
civet
sarscov
isol
reveal
high
nonsynonymoussynonym
nucleotid
substitut
ratio
indic
ongo
mutat
evolv
process
viru
civet
suggest
palm
civet
unlik
natur
reservoir
viru
high
preval
antisarscov
antibodi
detect
serolog
survey
involv
peopl
infect
sarscov
work
retail
busi
palm
civet
indic
crosstransmiss
precursor
sarscov
probabl
occur
actual
sar
epidem
past
inabl
cultur
isol
virus
greatli
hinder
studi
virus
understand
viral
ecolog
divers
develop
metagenom
sequenc
technolog
enabl
discoveri
new
viral
speci
cultureindepend
sequenceindepend
manner
contribut
significantli
field
viral
metagenom
advanc
made
technolog
abl
carri
high
throughput
sequenc
larg
viral
genom
miniscul
amount
viral
dna
sampl
greatli
aid
discoveri
mani
coronavirus
largest
rna
virus
known
far
particularli
bat
sinc
sar
epidem
huge
divers
sarslik
coronavirus
slcov
coronavirus
high
sequenc
homolog
human
sarscov
epidem
strain
discov
bat
mani
countri
across
world
includ
south
east
asian
european
african
countri
review
see
ref
howev
bat
slcov
fail
grow
cell
cultur
present
barrier
understand
viral
replic
pathogenesi
improv
revers
genet
system
coronaviru
allow
method
wide
use
construct
live
sarscov
use
system
enorm
amount
inform
deriv
metagenom
sequenc
could
util
creat
synthet
coronaviru
clone
allow
studi
virus
perform
identifi
potenti
emerg
caus
diseas
human
herein
summar
find
recent
public
highlight
import
technolog
advanc
studi
slcov
potenti
caus
futur
pandem
separ
group
report
identif
genom
sequenc
slcov
horsesho
bat
genu
rhinolophu
china
import
breakthrough
identifi
bat
natur
reservoir
sarscov
bat
slcov
share
high
genom
sequenc
homolog
human
sarscov
epidem
strain
howev
variat
spike
gene
sequenc
hover
greater
sequenc
differ
domain
compar
domain
gene
coronaviru
encod
surfac
spike
protein
consist
region
respons
receptor
bind
cellvir
membran
fusion
respect
viral
entri
process
unlik
human
sarscov
util
angiotensinconvert
enzym
receptor
viral
entri
bat
slcov
recogn
receptor
henc
unabl
infect
human
cell
suggest
unlik
direct
progenitor
human
sarscov
recent
ge
et
al
report
discoveri
novel
bat
slcov
sequenc
chines
horsesho
bat
rhinolophu
sinicu
share
high
sequenc
homolog
human
sarscov
particularli
receptor
bind
domain
rbd
region
protein
requir
bind
receptor
slcov
sequenc
repres
closest
relat
ancestor
human
sarscov
studi
live
bat
slcov
term
high
sequenc
ident
success
isol
cultur
vero
cell
first
time
demonstr
abl
infect
cell
bat
human
origin
via
recognit
receptor
provid
concret
evid
sarscov
origin
bat
also
demonstr
possibl
reemerg
emerg
sar
sarslik
virus
human
continu
persist
slcov
bat
reservoir
use
metagenom
find
bat
slcov
menacheri
et
al
describ
use
revers
genet
system
gener
fulllength
well
chimer
virus
consist
protein
backbon
sarscov
mous
adapt
strain
vitro
vivo
method
slcov
character
fulllength
well
chimer
replic
effici
vero
cell
bind
human
receptor
replic
also
observ
primari
human
epitheli
cell
level
similar
human
sarscov
epidem
strain
urbani
mous
model
caus
weight
loss
limit
diseas
oppos
result
seriou
diseas
mortal
addit
fulllength
although
unabl
result
observ
weight
loss
mice
abl
replic
lung
attenu
level
compar
human
sarscov
urbani
togeth
find
suggest
inabl
caus
seriou
diseas
adapt
virus
would
necessari
effici
infect
replic
human
nonetheless
augment
replic
presenc
human
receptor
signifi
potenti
pathogen
emerg
human
studi
menacheri
et
al
also
evalu
effect
therapeut
monoclon
antibodi
mab
vaccin
approach
sar
treatment
protect
mab
target
human
sarscov
protein
within
rbd
region
could
crossneutr
vitro
vivo
mab
target
outsid
rbd
region
could
confer
partial
neutral
hand
mab
unabl
neutral
effici
compar
attribut
differ
bind
affin
mab
epitop
protein
mice
vaccin
inactiv
whole
sarscov
virion
protect
virus
found
incomplet
find
indic
use
mab
target
region
sarscov
protein
inactiv
whole
sarscov
virion
particl
treat
prevent
sarscov
infect
may
capabl
confer
full
protect
event
outbreak
caus
slcov
know
slcov
circul
bat
certain
potenti
emerg
human
current
therapeut
vaccin
strategi
may
effect
enough
protect
bat
slcov
import
develop
novel
therapeut
vaccin
abl
protect
human
sarscov
also
bat
slcov
strain
passiv
immunotherapi
involv
administr
mab
promis
antivir
treatment
prophylact
strategi
evid
zmapp
palivizumab
effect
prevent
ebola
respiratori
syncyti
viru
infect
human
respect
number
neutral
mab
act
bind
protein
sarscov
inhibit
viral
entri
character
preclin
serv
potenti
candid
passiv
immunotherapi
sar
complet
review
see
ref
mab
bind
rbd
domain
neutral
viral
infect
prevent
rbd
interact
receptor
sarscovneutr
mab
inhibit
viral
entri
disrupt
viralcel
membran
fusion
process
sinc
region
human
sarscov
bat
slcov
conserv
compar
region
mab
target
domain
broadli
neutral
confer
crossprotect
bat
slcov
identif
broadspectrum
inhibitor
target
highli
conserv
protein
human
sarscov
bat
slcov
proteas
well
inhibitor
target
import
host
protein
requir
viral
entri
pathogenesi
host
surfac
endosom
cystein
proteas
feasibl
way
develop
novel
broadlyneutr
sar
therapeut
full
review
see
ref
vaccin
develop
comprehens
understand
covinduc
immun
necessari
identif
conserv
epitop
human
sarscov
bat
slcov
give
rise
crossneutr
antibodi
cell
respons
lead
vaccin
strategi
crossprotect
virus
emerg
anoth
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
decad
sar
epidem
certainli
prove
introduct
novel
coronaviru
human
zoonot
sourc
oneoff
event
although
merslik
coronavirus
found
wildlif
bat
suggest
bat
origin
dromedari
camel
play
critic
role
main
reservoir
continu
zoonot
transmiss
viru
human
popul
middl
east
merscov
like
sarscov
caus
seriou
lower
respiratori
tract
infect
human
well
extrapulmonari
manifest
fatal
although
dissimilar
transmiss
clinic
present
pathogenesi
could
observ
th
juli
world
health
organ
report
total
mer
case
death
repres
fatal
rate
around
rate
much
higher
sar
sar
epidem
occur
swiftli
effect
brought
end
month
intens
public
health
effort
merscov
persist
number
affect
individu
continu
escal
fortun
merscov
remain
incap
sustain
humantohuman
transmiss
compar
sarscov
rel
welladapt
transmiss
human
intens
research
effort
place
merscov
understand
novel
virul
coronaviru
well
develop
therapeut
vaccin
full
review
see
ref
although
sarscov
merscov
classifi
order
nidoviral
famili
coronavirida
phylogenet
distinct
sarscov
belong
lineag
b
merscov
belong
lineag
c
betacoronaviru
genu
nonetheless
sever
research
group
report
develop
broadspectrum
pancoronaviru
treatment
vaccin
strategi
includ
effect
sarscov
merscov
instanc
drug
target
coronaviru
proteas
papainlik
proteas
plpro
inhibit
sarscov
merscov
vitro
glycopeptid
antibiot
known
teicoplanin
block
viral
entri
sarscov
merscov
host
cell
inhibit
cathepsin
l
enzym
requir
viral
entri
via
endosom
pathway
vaccin
conserv
c
cell
epitop
locat
within
merscov
nucleocapsid
protein
transgen
mous
model
abl
induc
crossreact
cell
could
provid
crossprotect
sarscov
challeng
light
dwindl
interest
sar
research
last
year
mer
research
contribut
advanc
develop
pancoronaviru
therapeut
option
also
effect
sarscov
coronavirus
capabl
mutat
high
frequenc
due
infidel
rnadepend
rna
polymeras
high
rate
homolog
rna
recombin
full
review
see
ref
provid
opportun
coronavirus
achiev
high
divers
speci
spillov
lead
possibl
futur
outbreak
human
ultim
knowledg
zoonot
bat
slcov
well
coronaviru
speci
high
potenti
emerg
human
paramount
import
surveil
futur
outbreak
caus
coronavirus
steer
futur
research
direct
treatment
vaccin
develop
